...
首页> 外文期刊>Lipids in Health Disease >Lipoprotein (a) as a residual risk factor for atherosclerotic renal artery stenosis in hypertensive patients: a hospital-based cross-sectional study
【24h】

Lipoprotein (a) as a residual risk factor for atherosclerotic renal artery stenosis in hypertensive patients: a hospital-based cross-sectional study

机译:脂蛋白(a)作为高血压患者动脉粥样硬化肾动脉狭窄的残留危险因素:基于医院的横截面研究

获取原文

摘要

Low-density lipoprotein cholesterol (LDL-c) has been proven to be a risk factor for atherosclerotic cardiovascular disease (CVD), while lipoprotein (a) (Lp(a)) is a residual risk factor for CVD, even though LDL-c is well controlled by statin use. Importantly, the role of Lp(a) in atherosclerotic renal artery stenosis (ARAS) is still unknown. For this hospital-based cross-sectional study, patients who simultaneously underwent coronary and renal angiography were examined. ARAS was defined as a 50% reduction in the cross-sectional (two-dimensional plane) area of the renal artery. Data were collected and compared between ARAS and non-ARAS groups, including clinical history and metabolite profiles. Univariate analysis, three tertile LDL-c-based stratified analysis, and multivariate-adjusted logistic analysis were conducted, revealing a correlation between Lp(a) and ARAS. A total of 170 hypertensive patients were included in this study, 85 with ARAS and 85 with non-RAS. Baseline information indicated comparability between the two groups. In the univariate and multivariate analysis, common risk factors for atherosclerosis were not significantly different. Stratified analysis of LDL-c revealed a significant increase in the incidence of ARAS in patients who had high Lp(a) concentrations at low LDL-c levels (odds ratio (OR): 4.77, 95% confidence interval (CI): 1.04–21.79, P?=?0.044). Further logistic analysis with adjusted covariates also confirmed the result, indicating that high Lp(a) levels were independently associated with ARAS (adjusted OR (aOR): 6.14, 95%CI: 1.03–36.47, P?=?0.046). This relationship increased with increasing Lp(a) concentration based on a curve fitting graph. These results were not present in the low and intermediate LDL-c-level groups. In hypertensive patients who present low LDL-c, high Lp(a) was significantly associated with atherosclerotic renal artery stenosis and thus is a residual risk factor.
机译:已经证明,低密度脂蛋白胆固醇(LDL-C)是动脉粥样硬化心血管疾病(CVD)的危险因素,而脂蛋白(A)(LP(a))是CVD的残余危险因素,即使LDL-C通过他汀类药物使用良好控制。重要的是,LP(a)在动脉粥样硬化肾动脉狭窄(ARAS)中的作用仍然未知。对于这种基于医院的横截面研究,检查了同时进行了冠状动脉和肾血管造影的患者。 ARAS被定义为肾动脉的横截面(二维平面)区域的50%降低。收集数据,并在ARAS和非ARAS组之间进行比较,包括临床历史和代谢物轮廓。单变量分析,进行三种基于Tertile LDL-C基分层分析和多变量调节的物流分析,揭示LP(A)和ARAS之间的相关性。本研究共用了170名高血压患者,85名与非RAS的ARAS和85。基线信息指示两组之间的可比性。在单变量和多变量分析中,动脉粥样硬化的常见风险因素没有显着差异。 LDL-C的分层分析显示,在低LDL-C水平下具有高LP(A)浓度的患者中ARAs的发生率显着增加(OTS比(或):4.77,95%置信区间(CI):1.04- 21.79,p?= 0.044)。使用调整后的协变量的进一步物流分析也证实了结果,表明高LP(A)水平与ARAs独立相关(调节或(AOR):6.14,95%CI:1.03-36.47,P?= 0.046)。这种关系随着基于曲线拟合图的LP(A)浓度而增加。这些结果不存在于低和中间LDL-C级基团中。在呈现低LDL-C的高血压患者中,高LP(A)显着与动脉粥样硬化肾动脉狭窄显着相关,因此是残留的危险因素。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号